A graduate of Medicine and Surgery from the Autonomous University of Barcelona (UAB) and specialist in ophthalmology, he did a Surgical Retina Fellowship at the Barraquer Ophthalmology Centre and gained his PhD cum laude from the UAB. He was awarded excellence in research by the University of Barcelona. He undertook additional training at the Mayo Clinic, Rochester, Minnesota (United States). He is currently the deputy medical director and coordinator of the Retina and Vitreous Department at the Barraquer Ophthalmology Centre.
Jeroni Nadal stands out for being an international driving force and pioneer in the field of artificial vision. In 2014, he became the first surgeon in Spain to implant a bionic eye with the Argus II device, a procedure that took place at the Barraquer Ophthalmology Centre. The same procedure saw him become the first surgeon in the world to rehabilitate a patient with deafblindness, caused by Usher syndrome. Nadal currently continues to participate in the development of this field and is co-director of HOPE (High Optical Resolution Pixel Electrodes Retinal Implant) artificial vision project and is the lead researcher on i-VISION, an international project. In addition to artificial vision, Jeroni Nadal further develops his work as a researcher in two other areas: gene therapy and cell therapy.
His career has led to him being elected president of the Catalan Ophthalmology Society (2018), to belonging to multiple scientific associations and receiving a long list of recognitions.
- Barraquer Ophthalmology Centre deputy medical director and coordinator of the Retina and Vitreous Department
- Member of the Barraquer Institute Medical Board
- President of the Catalan Ophthalmology Society
- Member No 15 of the European Academy of Ophthalmology
- Bist Ignite prize, awarded by the BIST (Barcelona Institute of Science and Technology) for the HOPE artificial vision project (2017)
- Mateu Orfila prize of the Royal Academy of Medicine of the Balearic Islands (2016)
- Jaume II prize of the Insular Council of Mallorca (2016)
- Award Best of the Show of the American Academy of Ophthalmology
- Author of four patents being developed for vitreous and retina surgery instruments
- Vitrectomy for Endophthalmitis in Eyes with Osteokeratoprothesis. Vilaplana F, Nadal J, Temprano J, Julio G, Olivera M, Casaroli-Marano RP, Barraquer RI. Retina. 2019 Mar 5. doi: 10.1097/IAE.0000000000002495.
- Efficacy of Internal Limiting Membrane Flap Techniques with Vitrectomy for Macular Detachment Associated with an Optic Disc Pit. Pastor-Idoate S, Gómez-Resa M, Karam S, Copete S, Kyriakou D, García-Arumí Fusté C, Pastora N, Nadal J, García-Arumí J. Ophthalmologica. 2019 Mar 1:38-48. doi: 10.1159/000495621. Epub 2019 Mar 22.
- Long-term visual outcomes and rehabilitation in Usher syndrome type II after retinal implant Argus II. Nadal J, Iglesias M. BMC Ophthalmol. 2018 Aug 22;18(1):205. doi: 10.1186/s12886-018-0880-5.
- Results of Retinal Detachment Surgery in Eyes With Osteo-Keratoprothesis. Vilaplana F, Nadal J, Temprano J, Julio G, Barraquer RI. Retina. 2018 Dec;38(12):2336-2342. doi: 10.1097/IAE.0000000000001865.
- Reduction of foveal bulges and other anatomical changes in fellow eyes of patients with unilateral idiopathic macular hole without vitreomacular pathologic changes. Delas B, Julio G, Fernández-Vega Á, Casaroli-Marano RP, Nadal J. Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2141-2146. doi: 10.1007/s00417-017-3765-z. Epub 2017 Aug 23.